{
  "company": "Guardant Health",
  "ticker": "GH",
  "period": {
    "from": "2026-03-02",
    "to": "2026-04-01",
    "days": 30
  },
  "sentiment_breakdown": {
    "positive": 47,
    "negative": 75,
    "neutral": 50
  },
  "synthesis": {
    "executive_summary": "**Executive Summary: Guardant Health (GH) Sentiment Analysis**\n\nGuardant Health (GH) exhibited a predominantly negative sentiment during the period of March 2 to April 1, 2026. Out of 172 analyzed items, 75 (43.6%) were classified as negative, significantly outweighing the 47 (27.3%) positive and 50 (29.1%) neutral items. A review of the top positive sentiment drivers indicates that many articles were not directly related to Guardant Health's core business or the broader oncology sector, suggesting limited direct positive impact on the company's market perception from these sources.\n\nConversely, key negative sentiment drivers included highly relevant developments within the oncology landscape. A significant negative event was a PubMed publication detailing resistance to next-generation ER\\u03b1 antagonists in breast cancer, highlighting ongoing challenges in cancer treatment. Additionally, a GlobeNewswire report on colorectal cancer advocates urging increased research funding underscored unmet needs and potential pressures within a key market segment for Guardant Health. These relevant negative trends warrant close monitoring as they reflect critical challenges and advocacy efforts within the cancer diagnostics and treatment space.",
    "key_findings": [
      "✓ Show HN: Open Source 'Conductor + Ghostty'",
      "✓ Holding it all together: Family caregivers’ support needs after very early supported discharge post stroke",
      "✓ Heath Goldfields Has Brought Renewed Hope To Prestea-Bogoso -Group",
      "✗ Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER(+) HER2(-) locally-advanced or metastatic breast cancer.",
      "✗ Police Gun Down Suspected Armed Robber on Atebubu–Ejura Highway",
      "✗ Colorectal Cancer Advocates Urge Congress to Fund New Research"
    ],
    "overall_sentiment": "negative"
  },
  "top_positive": [
    {
      "title": "Show HN: Open Source 'Conductor + Ghostty'",
      "date": "2026-03-27",
      "source": "news",
      "score": 0.883
    },
    {
      "title": "Holding it all together: Family caregivers’ support needs after very early supported discharge post stroke",
      "date": "2026-03-26",
      "source": "news",
      "score": 0.88
    },
    {
      "title": "Heath Goldfields Has Brought Renewed Hope To Prestea-Bogoso -Group",
      "date": "2026-03-31",
      "source": "news",
      "score": 0.844
    },
    {
      "title": "Donors cheer up SHS Arts students for decorating Asokwa Interchange",
      "date": "2026-03-30",
      "source": "news",
      "score": 0.827
    },
    {
      "title": "wizardenv added to PyPI",
      "date": "2026-03-30",
      "source": "news",
      "score": 0.758
    },
    {
      "title": "Fashion Designer remanded over alleged possession, use of counterfeit money",
      "date": "2026-03-27",
      "source": "news",
      "score": 0.758
    },
    {
      "title": "Mikael Barbero: Don't become the next Trivy: how to make your releases, tags, and automation resistant to compromise",
      "date": "2026-03-26",
      "source": "news",
      "score": 0.751
    },
    {
      "title": "Guardant Health's InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan",
      "date": "2026-03-30",
      "source": "reddit",
      "score": 0.735
    },
    {
      "title": "ECG delivers an impressive operational performance in 2025",
      "date": "2026-03-27",
      "source": "news",
      "score": 0.727
    },
    {
      "title": "GH’s Marco Star Adrian Anchondo Gets Tribute From Boyfriend After Exit",
      "date": "2026-03-27",
      "source": "news",
      "score": 0.713
    }
  ],
  "top_negative": [
    {
      "title": "Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER(+) HER2(-) locally-advanced or metastatic breast cancer.",
      "date": "2026 Apr 1",
      "source": "pubmed",
      "score": -1.0
    },
    {
      "title": "Police Gun Down Suspected Armed Robber on Atebubu–Ejura Highway",
      "date": "2026-03-30",
      "source": "news",
      "score": -0.95
    },
    {
      "title": "Colorectal Cancer Advocates Urge Congress to Fund New Research",
      "date": "2026-03-27",
      "source": "news",
      "score": -0.945
    },
    {
      "title": "Editorial: Ghana’s Tomato Crisis Is A Policy Failure!",
      "date": "2026-03-24",
      "source": "news",
      "score": -0.918
    },
    {
      "title": "Businessman Jailed 24 Months for GH¢180,000 Visa Fraud",
      "date": "2026-03-27",
      "source": "news",
      "score": -0.9
    },
    {
      "title": "Two Jailed for Stealing Motorbike Worth GH¢10,500",
      "date": "2026-03-27",
      "source": "news",
      "score": -0.883
    },
    {
      "title": "Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial",
      "date": "2026-03-27",
      "source": "news",
      "score": -0.869
    },
    {
      "title": "Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration.",
      "date": "2026 Mar 2",
      "source": "pubmed",
      "score": -0.869
    },
    {
      "title": "Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.",
      "date": "2026 Mar 4",
      "source": "pubmed",
      "score": -0.869
    },
    {
      "title": "Dispatch Rider Pleads Guilty To Robbing  Namibian High Commissioner’s Secretary",
      "date": "2026-03-24",
      "source": "news",
      "score": -0.832
    }
  ],
  "raw_data": {
    "total_items": 172,
    "items": [
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Show HN: HolyCode – OpenCode in Docker. Use your Claude subscription. 30 tools",
        "description": "HolyCode is a Docker image that wraps OpenCode (https://opencode.ai), an AI coding agent with a web UI. It ships with 30+ dev tools pre-installed, a headless Chromium/Xvfb/Playwright stack, s6-overlay for process supervision, and UID/GID remapping for correct…",
        "url": "https://github.com/CoderLuii/HolyCode",
        "date": "2026-03-31",
        "published_at": "2026-03-31T08:29:46Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Heath Goldfields Has Brought Renewed Hope To Prestea-Bogoso -Group",
        "description": "Hope has been rekindled in the Prestea-Bogoso enclave following the rapid revival of mining operations by Heath Goldfields, with residents and stakeholders calling on government to safeguard the company’s growing investment. At a press conference held yesterd…",
        "url": "https://thechronicle.com.gh/heath-goldfields-has-brought-renewed-hope-to-prestea-bogoso-group/",
        "date": "2026-03-31",
        "published_at": "2026-03-31T08:04:42Z",
        "sentiment": {
          "label": "positive",
          "score": 0.844,
          "confidence": 0.84
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Tarkwa Court Remands Two Students Over Supermarket Break-In and Theft",
        "description": "The Circuit Court in Tarkwa has remanded two young men, including a student of Takoradi Technical University, into custody for allegedly stealing cash and goods from a local supermarket. The accused, Kingsford Quarshie, also known as “Cash Money,” 21, a miner…",
        "url": "https://thechronicle.com.gh/tarkwa-court-remands-two-students-over-supermarket-break-in-and-theft/",
        "date": "2026-03-31",
        "published_at": "2026-03-31T07:56:13Z",
        "sentiment": {
          "label": "negative",
          "score": -0.71,
          "confidence": 0.71
        }
      },
      {
        "source": "news",
        "source_name": "Droppedasbaby.com",
        "title": "Accidentally created my first fork bomb with Claude Code",
        "description": "Accidentally created my first fork bomb with Claude Code, bricked my computer overnight, and somehow built useful tools along the way.",
        "url": "https://www.droppedasbaby.com/posts/2602-01/",
        "date": "2026-03-31",
        "published_at": "2026-03-31T07:40:18Z",
        "sentiment": {
          "label": "negative",
          "score": -0.649,
          "confidence": 0.65
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Show HN: Claudebase: Sync your Claude Code env across machines via GitHub",
        "description": "Article URL: https://github.com/rohithzr/claudebase\nComments URL: https://news.ycombinator.com/item?id=47583664\nPoints: 1\n# Comments: 0",
        "url": "https://github.com/rohithzr/claudebase",
        "date": "2026-03-31",
        "published_at": "2026-03-31T06:53:23Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "deathstar-ai added to PyPI",
        "description": "Secure AWS-hosted remote AI coding workstation with a provider-agnostic local CLI.",
        "url": "https://pypi.org/project/deathstar-ai/",
        "date": "2026-03-31",
        "published_at": "2026-03-31T06:15:04Z",
        "sentiment": {
          "label": "positive",
          "score": 0.34,
          "confidence": 0.34
        }
      },
      {
        "source": "news",
        "source_name": "ComingSoon.net",
        "title": "Sofia Mattsson’s New Soap Casting Revealed After General Hospital Exit",
        "description": "Sofia Mattsson is making a dramatic move after her seven-year stint as Sasha Gilmore on General Hospital. After exiting the ABC drama, Mattsson has been busy preparing for her next chapter. With her extensive experience in daytime drama, the Swedish-born actr…",
        "url": "https://www.comingsoon.net/tv/news/2114104-sofia-mattsson-cast-days-of-our-lives-general-hospital",
        "date": "2026-03-31",
        "published_at": "2026-03-31T05:56:58Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Agent-Reach - Give your AI agent eyes to see the entire internet",
        "description": "Give your AI agent eyes to see the entire internet. Read & search Twitter, Reddit, YouTube, GitHub, Bilibili, XiaoHongShu — one CLI, zero API fees. - Panniantong/Agent-Reach",
        "url": "https://github.com/Panniantong/Agent-Reach",
        "date": "2026-03-31",
        "published_at": "2026-03-31T05:47:01Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Deadline",
        "title": "Sofia Mattsson Joins ‘Days Of Our Lives’ Following ‘General Hospital’ Departure",
        "description": "Salem is getting a new resident in Sofia Mattsson. The former General Hospital actress will be jumping networks to NBC’s Days of our Lives, the soap announced in a joint post shared to Instagram. “Sofia Mattsson is making her way to Salem early next year! ⏳…",
        "url": "http://deadline.com/2026/03/sofia-mattsson-days-of-our-lives-cast-addition-1236769635/",
        "date": "2026-03-31",
        "published_at": "2026-03-31T02:48:43Z",
        "sentiment": {
          "label": "positive",
          "score": 0.4,
          "confidence": 0.4
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "aimio-py added to PyPI",
        "description": "Python bindings for the Numerics88 AimIO C++ library",
        "url": "https://pypi.org/project/aimio-py/",
        "date": "2026-03-31",
        "published_at": "2026-03-31T02:47:14Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "ez-stack 0.2.11",
        "description": "Stacked PRs for GitHub — agent-first CLI for parallel development",
        "url": "https://pypi.org/project/ez-stack/",
        "date": "2026-03-31",
        "published_at": "2026-03-31T00:17:47Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "acp-gh 1.5.0",
        "description": "Automatic Commit Pusher (acp) - CLI tool to create GitHub PRs from staged changes in a single command",
        "url": "https://pypi.org/project/acp-gh/1.5.0/",
        "date": "2026-03-30",
        "published_at": "2026-03-30T23:12:09Z",
        "sentiment": {
          "label": "positive",
          "score": 0.511,
          "confidence": 0.51
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Police Gun Down Suspected Armed Robber on Atebubu–Ejura Highway",
        "description": "The Ghana Police Service has allegedly shot dead a suspected notorious armed robber, Osman Amadu, popularly known as “Manu,” during an intelligence-led operation along the Atebubu–Ejura highway. According to police reports, the incident occurred on March 18, …",
        "url": "https://thechronicle.com.gh/police-gun-down-suspected-armed-robber-on-atebubu-ejura-highway/",
        "date": "2026-03-30",
        "published_at": "2026-03-30T17:22:17Z",
        "sentiment": {
          "label": "negative",
          "score": -0.95,
          "confidence": 0.95
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "gh-bin 2.89.0",
        "description": "A thin wrapper to distribute https://github.com/cli/cli via pip.",
        "url": "https://pypi.org/project/gh-bin/2.89.0/",
        "date": "2026-03-30",
        "published_at": "2026-03-30T16:16:36Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "wizardenv added to PyPI",
        "description": "A powerful AI SDK with vision, speech, and multi-backend support",
        "url": "https://pypi.org/project/wizardenv/",
        "date": "2026-03-30",
        "published_at": "2026-03-30T15:03:36Z",
        "sentiment": {
          "label": "positive",
          "score": 0.758,
          "confidence": 0.76
        }
      },
      {
        "source": "news",
        "source_name": "Stephenjude.me",
        "title": "How to Setup PIE for PHP Extensions on macOS",
        "description": "Pie is the official PHP extension installer and the replacement for PECL. In this article, I will show you how to get Pie up and running on your local machine.",
        "url": "https://stephenjude.me/articles/how-to-setup-pie-for-php-extensions-on-macos?utm_source=laravelnews&utm_medium=link&utm_campaign=laravelnews",
        "date": "2026-03-30",
        "published_at": "2026-03-30T13:00:00Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Donors cheer up SHS Arts students for decorating Asokwa Interchange",
        "description": "Individuals and institutions have trooped to the Asokwa Interchange with food, drinks and cash donations to support Visual Arts students from Senior High Schools who are engaged in decorating the Asokwa Interchange. The project forms part of the novelle Ashan…",
        "url": "https://thechronicle.com.gh/donors-cheer-up-shs-arts-students-for-decorating-asokwa-interchange/",
        "date": "2026-03-30",
        "published_at": "2026-03-30T12:05:55Z",
        "sentiment": {
          "label": "positive",
          "score": 0.827,
          "confidence": 0.83
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Filmmakers Summit Held in Kumasi to boost Kumawood Industry",
        "description": "A Filmmakers Summit has been held in Kumasi to revitalise the Ghanaian film industry as part of the Ashanti Festival 2026. Secretary to the Kumawood Board of Directors, Emmanuel Opoku Anane, said the summit is designed to enhance the industry’s vibrancy and s…",
        "url": "https://thechronicle.com.gh/filmmakers-summit-held-in-kumasi-to-boost-kumawood-industry/",
        "date": "2026-03-30",
        "published_at": "2026-03-30T12:01:36Z",
        "sentiment": {
          "label": "positive",
          "score": 0.71,
          "confidence": 0.71
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Gene Panel Market Size to Projected Reach USD 17.18 Billion by 2035, Driven by Precision Medicine Adoption – SNS Insider",
        "description": "Rising demand for early disease detection, expanding oncology applications, and rapid advancements in next-generation sequencing technologies propel market growth at 16.69% CAGR. Rising demand for early disease detection, expanding oncology applications, and …",
        "url": "https://www.globenewswire.com/news-release/2026/03/30/3264508/0/en/Gene-Panel-Market-Size-to-Projected-Reach-USD-17-18-Billion-by-2035-Driven-by-Precision-Medicine-Adoption-SNS-Insider.html",
        "date": "2026-03-30",
        "published_at": "2026-03-30T11:12:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.178,
          "confidence": 0.18
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Show HN: Ag.sh – All-in-one CLI tool to do parallelised AI development with ease",
        "description": "Command-line ADE tooling to run multiple Claude Code/AI agents in parallel - each in its own isolated git worktree.  Spawn, manage, and orchestrate AI-powered development across concurrent tasks wi...",
        "url": "https://github.com/andrewhathaway/ag.sh",
        "date": "2026-03-30",
        "published_at": "2026-03-30T11:01:13Z",
        "sentiment": {
          "label": "positive",
          "score": 0.052,
          "confidence": 0.05
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook",
        "description": "Rising demand for personalized oncology therapies, AI-driven biomarker discovery, expanding precision diagnostics, and liquid biopsy tech Rising demand for personalized oncology therapies, AI-driven biomarker discovery, expanding precision diagnostics, and li…",
        "url": "https://www.globenewswire.com/news-release/2026/03/30/3264368/28124/en/Oncology-Biomarkers-Market-Trends-and-Investment-Opportunities-Report-2026-2030-Global-Regional-and-Country-Level-Outlook.html",
        "date": "2026-03-30",
        "published_at": "2026-03-30T08:58:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.153,
          "confidence": 0.15
        }
      },
      {
        "source": "news",
        "source_name": "Pythonbytes.fm",
        "title": "Python Bytes: #475 Haunted warehouses",
        "description": "News and announcements from the Python community for the week of Mar 30th, 2026",
        "url": "https://pythonbytes.fm/episodes/show/475/haunted-warehouses",
        "date": "2026-03-30",
        "published_at": "2026-03-30T08:00:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.477,
          "confidence": 0.48
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "simonw/claude-code-transcripts: Tools for publishing transcripts for Claude Code sessions",
        "description": "Tools for publishing transcripts for Claude Code sessions - simonw/claude-code-transcripts",
        "url": "https://github.com/simonw/claude-code-transcripts",
        "date": "2026-03-30",
        "published_at": "2026-03-30T05:47:01Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "gh-worktree 0.3.1",
        "description": "github CLI extension for worktrees",
        "url": "https://pypi.org/project/gh-worktree/0.3.1/",
        "date": "2026-03-29",
        "published_at": "2026-03-29T22:48:33Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "claude-podman added to PyPI",
        "description": "Run Claude Code CLI in a Podman container with tmux, GitHub access, and persistent config",
        "url": "https://pypi.org/project/claude-podman/",
        "date": "2026-03-29",
        "published_at": "2026-03-29T19:35:55Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Show HN: Baton – A daemon that sends Claude to fix your GitHub issues",
        "description": "I got tired of the context-switching loop: pick an issue, read the context, write the code, open a PR, pick the next one. So I built Baton — a Python daemon that polls your GitHub issue tracker and dispatches Claude Code agents to work on them autonomously.Ho…",
        "url": "https://github.com/mraza007/baton",
        "date": "2026-03-29",
        "published_at": "2026-03-29T16:57:05Z",
        "sentiment": {
          "label": "negative",
          "score": -0.44,
          "confidence": 0.44
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "ansel-cli added to PyPI",
        "description": "don't leave crumbs in the woods",
        "url": "https://pypi.org/project/ansel-cli/",
        "date": "2026-03-29",
        "published_at": "2026-03-29T16:47:06Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.038,
          "confidence": 0.04
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "GitHub - axeldelafosse/loop: Dead-simple Bun CLI that runs Codex and Claude Code in a loop. · GitHub",
        "description": "axeldelafosse/loop: Dead-simple Bun CLI that runs Codex and Claude Code in a loop. https://ift.tt/KJUYeRg ai, codex, claude.code, programming",
        "url": "https://github.com/axeldelafosse/loop",
        "date": "2026-03-29",
        "published_at": "2026-03-29T05:47:02Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "gh-worktree 0.3.0",
        "description": "github CLI extension for worktrees",
        "url": "https://pypi.org/project/gh-worktree/0.3.0/",
        "date": "2026-03-28",
        "published_at": "2026-03-28T23:26:34Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "fastmvc-cli added to PyPI",
        "description": "FastMVC CLI — interactive FastAPI project generator and tooling",
        "url": "https://pypi.org/project/fastmvc-cli/",
        "date": "2026-03-28",
        "published_at": "2026-03-28T16:33:56Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Show HN: Open Source 'Conductor + Ghostty'",
        "description": "Our team works with Claude Code, Codex, Gemini all day.\nWe love Ghostty, but wanted something where we could work in multiple worktree at once and have multiple agents run.We decided to open source the internal team we use. Hope you might find it useful. Free…",
        "url": "https://github.com/stablyai/orca",
        "date": "2026-03-27",
        "published_at": "2026-03-27T22:26:40Z",
        "sentiment": {
          "label": "positive",
          "score": 0.883,
          "confidence": 0.88
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "acp-gh 1.4.0",
        "description": "Automatic Commit Pusher (acp) - CLI tool to create GitHub PRs from staged changes in a single command",
        "url": "https://pypi.org/project/acp-gh/1.4.0/",
        "date": "2026-03-27",
        "published_at": "2026-03-27T21:39:52Z",
        "sentiment": {
          "label": "positive",
          "score": 0.511,
          "confidence": 0.51
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Velxio 2.0 – Emulate Arduino, ESP32, and Raspberry Pi 3 in the Browser",
        "description": "Emulate Arduino, ESP32 &amp; Raspberry Pi. in your browser. Write code, compile, and run on 19 real boards — Arduino Uno, ESP32, ESP32-C3, Raspberry Pi Pico, Raspberry Pi 3, and more. No hardware, ...",
        "url": "https://github.com/davidmonterocrespo24/velxio",
        "date": "2026-03-27",
        "published_at": "2026-03-27T20:44:33Z",
        "sentiment": {
          "label": "negative",
          "score": -0.36,
          "confidence": 0.36
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Colorectal Cancer Advocates Urge Congress to Fund New Research",
        "description": "With Young Lives at Stake, More Than 250 Colorectal Cancer Advocates Demand Action With Young Lives at Stake, More Than 250 Colorectal Cancer Advocates Demand Action",
        "url": "https://www.globenewswire.com/news-release/2026/03/27/3263970/0/en/Colorectal-Cancer-Advocates-Urge-Congress-to-Fund-New-Research.html",
        "date": "2026-03-27",
        "published_at": "2026-03-27T16:31:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.945,
          "confidence": 0.95
        }
      },
      {
        "source": "news",
        "source_name": "Plos.org",
        "title": "Glucocorticoid-Induced alterations in DNA methylation in the H19 promoter of Bone Marrow-Derived Mesenchymal Stem Cells are associated with the pathogenesis of osteonecrosis",
        "description": "Background Glucocorticoid (GC)-induced osteonecrosis of the femoral head (ONFH) involves bone marrow-derived mesenchymal stem cell (BMSC) apoptosis and dysregulated osteo-adipogenic differentiation. While aberrant H19 promoter methylation and expression have …",
        "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345372",
        "date": "2026-03-27",
        "published_at": "2026-03-27T14:00:00Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Zinc Chemicals Market to Reach USD 16.17 Billion by 2035, Fueled by Rising Demand in Rubber, Agriculture, and Industrial Applications | Research by SNS Insider",
        "description": "The Zinc Chemicals Market is growing steadily as demand rises for zinc-based fertilizers, rubber additives, and industrial formulations, with the U.S. segment increasing from USD 1.86 billion in 2025 to USD 2.82 billion by 2035. The Zinc Chemicals Market is g…",
        "url": "https://www.globenewswire.com/news-release/2026/03/27/3263802/0/en/Zinc-Chemicals-Market-to-Reach-USD-16-17-Billion-by-2035-Fueled-by-Rising-Demand-in-Rubber-Agriculture-and-Industrial-Applications-Research-by-SNS-Insider.html",
        "date": "2026-03-27",
        "published_at": "2026-03-27T13:30:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.052,
          "confidence": 0.05
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "caalm added to PyPI",
        "description": "Carbohydrate Activity Annotation with protein Language Models",
        "url": "https://pypi.org/project/caalm/",
        "date": "2026-03-27",
        "published_at": "2026-03-27T08:29:51Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Two Jailed for Stealing Motorbike Worth GH¢10,500",
        "description": "The Circuit Court at Dansoman has sentenced two young men to prison for stealing a motorbike valued at GH¢10,500. The convicts, Abdul Aziz Osman, 20, unemployed and Abdul Aziz Mohammed, 22, also unemployed, were sentenced by the court presided over by Her Hon…",
        "url": "https://thechronicle.com.gh/two-jailed-for-stealing-motorbike-worth-gh¢10500/",
        "date": "2026-03-27",
        "published_at": "2026-03-27T08:00:45Z",
        "sentiment": {
          "label": "negative",
          "score": -0.883,
          "confidence": 0.88
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Fashion Designer remanded over alleged possession, use of counterfeit money",
        "description": "The Circuit Court in Tarkwa, presided over by Her Honour Bernice Mensimah Ackon, has remanded a 40-year-old fashion designer, Grace Arthur, into custody for allegedly possessing and uttering counterfeit Ghana cedi notes at Wasa Akropong in the Western Region.…",
        "url": "https://thechronicle.com.gh/fashion-designer-remanded-over-alleged-possession-use-of-counterfeit-money/",
        "date": "2026-03-27",
        "published_at": "2026-03-27T07:58:51Z",
        "sentiment": {
          "label": "positive",
          "score": 0.758,
          "confidence": 0.76
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Businessman Jailed 24 Months for GH¢180,000 Visa Fraud",
        "description": "The Dansoman Circuit Court has sentenced a 29-year-old businessman, Charles Komla Asigbey, to 24 months imprisonment for defrauding seven persons of GH¢180,000 under the pretext of securing visas for them to travel abroad. The court, presided over by Her Hono…",
        "url": "https://thechronicle.com.gh/businessman-jailed-24-months-for-gh¢180000-visa-fraud/",
        "date": "2026-03-27",
        "published_at": "2026-03-27T07:56:52Z",
        "sentiment": {
          "label": "negative",
          "score": -0.9,
          "confidence": 0.9
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "ECG delivers an impressive operational performance in 2025",
        "description": "The Eastern Regional office of the Electricity Company of Ghana (ECG) has delivered an impressive operational performance in 2025, underpinned by improved power stability, strategic infrastructure investments, and a renewed crackdown on illegal electricity us…",
        "url": "https://thechronicle.com.gh/ecg-delivers-an-impressive-operational-performance-in-2025/",
        "date": "2026-03-27",
        "published_at": "2026-03-27T07:46:12Z",
        "sentiment": {
          "label": "positive",
          "score": 0.727,
          "confidence": 0.73
        }
      },
      {
        "source": "news",
        "source_name": "ComingSoon.net",
        "title": "GH’s Marco Star Adrian Anchondo Gets Tribute From Boyfriend After Exit",
        "description": "Fans have bid farewell to General Hospital‘s Marco, portrayed by Adrian Anchondo, and his boyfriend has now shared his reaction to his exit. Fellow soap opera star Colton Little shared an emotional tribute after Anchondo’s surprise departure from GH. Adrian A…",
        "url": "https://www.comingsoon.net/tv/news/2112893-general-hospital-gh-adrian-anchondo-leave-exit-marco-death-reaction",
        "date": "2026-03-27",
        "published_at": "2026-03-27T05:24:50Z",
        "sentiment": {
          "label": "positive",
          "score": 0.713,
          "confidence": 0.71
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Haruna Iddrisu throws $27,000 lifeline for fourth surgery of six-year-old boy",
        "description": "The Member of Parliament for Tamale North, Haruna Iddrisu, has funded a fourth life-saving surgery for a six-year-old boy, Abdula Hannan at the KomfoAnokye Teaching Hospital.The little boy has a prolonged medical condition caused by accidental ingestion of a …",
        "url": "https://thechronicle.com.gh/haruna-iddrisu-throws-27000-lifeline-for-fourth-surgery-of-six-year-old-boy/",
        "date": "2026-03-27",
        "published_at": "2026-03-27T00:41:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.077,
          "confidence": 0.08
        }
      },
      {
        "source": "news",
        "source_name": "Nature.com",
        "title": "Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial",
        "description": "In the nonpivotal stage 1 of the randomized phase 3 PRESERVE-003 trial, patients with immunochemotherapy-resistant metastatic squamous non-small cell lung cancer without actionable genomic alterations treated with the next-generation, pH-sensitive anti-CTLA-4…",
        "url": "https://www.nature.com/articles/s41591-026-04323-8",
        "date": "2026-03-27",
        "published_at": "2026-03-27T00:00:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.869,
          "confidence": 0.87
        }
      },
      {
        "source": "news",
        "source_name": "Royal Society of Chemistry",
        "title": "Atmosphere-dependent synthesis and crystallization behavior of silica nanoparticles derived from rice husk biomass",
        "description": "RSC Adv., 2026, 16,16874-16886DOI: 10.1039/D6RA00367B, Paper Open Access &nbsp This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Fuad Hama Shareef Radha, Mohammad Tahir Kareem, Omed Gh. AbdullahThis work on sustainable nanomat…",
        "url": "https://pubs.rsc.org/en/content/articlelanding/2026/ra/d6ra00367b",
        "date": "2026-03-27",
        "published_at": "2026-03-27T00:00:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.44,
          "confidence": 0.44
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "ticktick-agent-cli added to PyPI",
        "description": "Agent-native CLI for TickTick task management — full API coverage via V1 + V2",
        "url": "https://pypi.org/project/ticktick-agent-cli/",
        "date": "2026-03-26",
        "published_at": "2026-03-26T23:19:31Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results",
        "description": "NASHVILLE, Tenn., March 26, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its fourth quarter results:",
        "url": "https://www.globenewswire.com/news-release/2026/03/26/3263407/0/en/IMDX-Submits-GraftAssureDx-for-FDA-Review-and-Reports-Q4-2025-Results.html",
        "date": "2026-03-26",
        "published_at": "2026-03-26T20:05:00Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "gh-license 0.4.0",
        "description": "Scan github, bitbucket or other providers repositories for missing license files and add them",
        "url": "https://pypi.org/project/gh-license/0.4.0/",
        "date": "2026-03-26",
        "published_at": "2026-03-26T18:26:05Z",
        "sentiment": {
          "label": "negative",
          "score": -0.296,
          "confidence": 0.3
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "rcpilot added to PyPI",
        "description": "Lightweight self-hosted session manager for Claude Code Remote Control",
        "url": "https://pypi.org/project/rcpilot/",
        "date": "2026-03-26",
        "published_at": "2026-03-26T17:43:19Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Ssrf.dev",
        "title": "個人的にGitHub Actionsまわりで気をつけていること | ssrf.dev",
        "description": "目次ghalint / actionlintに頼る3rd party actionをできるだけ使わないSecretsにKeyを置かないやろうと思っているけど徹底できていないことRequire actions to be pinned to a full-length commit SHAの有効化branch ruleset / push rulesetghalint / actionlintを全リポジトリで回すさいごに 2026年も引き続きGitHub Ac...",
        "url": "https://ssrf.dev/posts/2026/03/27/personal-gha-security-tips/",
        "date": "2026-03-26",
        "published_at": "2026-03-26T16:50:38Z",
        "sentiment": {
          "label": "positive",
          "score": 0.599,
          "confidence": 0.6
        }
      },
      {
        "source": "news",
        "source_name": "Plos.org",
        "title": "Holding it all together: Family caregivers’ support needs after very early supported discharge post stroke",
        "description": "Background Early supported discharge (ESD) facilitates the transition from specialized stroke units to home-based rehabilitation in familiar environments. While ESD has shown positive outcomes for people with stroke, little is known about how their family car…",
        "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345795",
        "date": "2026-03-26",
        "published_at": "2026-03-26T14:00:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.88,
          "confidence": 0.88
        }
      },
      {
        "source": "news",
        "source_name": "Plos.org",
        "title": "Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A",
        "description": "Background Cancer progression involves coordinated regulation of oncogenes and tumor suppressors. This study explores the interplay of ENOX2 (ecto-NADH oxidase disulfide-thiol exchanger 2), MMP2 (matrix metalloproteinase-2), and regulatory genes Ras Associati…",
        "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345701",
        "date": "2026-03-26",
        "published_at": "2026-03-26T14:00:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.791,
          "confidence": 0.79
        }
      },
      {
        "source": "news",
        "source_name": "Plos.org",
        "title": "Cell cycle dynamics regulate H3K27 and H3K9 histone modifications in Drosophila",
        "description": "Previous studies have established a link between cell cycle progression and histone modification dynamics, but how this is regulated in vivo has remained largely explored. This study shows that the levels of H3K27ac, H3K27me3, and H3K9me3 are tightly linked t…",
        "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003371",
        "date": "2026-03-26",
        "published_at": "2026-03-26T14:00:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.273,
          "confidence": 0.27
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "ghboot added to PyPI",
        "description": "Bootstrap an empty directory into a git repo with a GitHub remote",
        "url": "https://pypi.org/project/ghboot/",
        "date": "2026-03-26",
        "published_at": "2026-03-26T12:06:22Z",
        "sentiment": {
          "label": "negative",
          "score": -0.202,
          "confidence": 0.2
        }
      },
      {
        "source": "news",
        "source_name": "Barbero.tech",
        "title": "Mikael Barbero: Don't become the next Trivy: how to make your releases, tags, and automation resistant to compromise",
        "description": "This is Part 2 of our response to the Trivy supply-chain compromise. Part 1 covered how to consume GitHub Actions safely. This post covers the other side: how to publish safely, so your project doesn’t become the upstream incident that impacts everyone downst…",
        "url": "https://mikael.barbero.tech/blog/post/2026-03-26-dont-become-the-next-trivy/",
        "date": "2026-03-26",
        "published_at": "2026-03-26T08:30:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.751,
          "confidence": 0.75
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "MIIF Records GH¢5.3bn in Mineral Royalties in 2025 – Up from GH¢4.91bn in 2024",
        "description": "When the Chief Executive Officer (CEO) of the Minerals Income Investment Fund (MIIF), Justina Nelson, addressed editors and senior journalists in Accra, yesterday, she set the tone with a defining statistic, MIIF recorded GH¢5.3 billion in mineral royalties i…",
        "url": "https://thechronicle.com.gh/miif-records-gh¢5-3bn-in-mineral-royalties-in-2025-up-from-gh¢4-91bn-in-2024/",
        "date": "2026-03-26",
        "published_at": "2026-03-26T08:15:50Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Rising Kidney Disease Burden Triggers Fresh Push for Food Labelling Reform",
        "description": "A growing body of scientific and public health evidence is raising alarms over the rapid rise of Chronic Kidney Disease (CKD) in Ghana. Policy advocates are now calling for urgent reforms to the country’s food labelling system to curb what they describe as a …",
        "url": "https://thechronicle.com.gh/rising-kidney-disease-burden-triggers-fresh-push-for-food-labelling-reform/",
        "date": "2026-03-26",
        "published_at": "2026-03-26T08:06:08Z",
        "sentiment": {
          "label": "negative",
          "score": -0.052,
          "confidence": 0.05
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Editorial: Ghana Is Paying Billions To Treat A Disease It Could Have Prevented",
        "description": "Four million Ghanaians, according to available statistics, are living with chronic kidney disease, but regrettably, most of them do not know it. The condition advances without symptoms, recruiting patients silently until it reaches the stage where the only av…",
        "url": "https://thechronicle.com.gh/editorial-ghana-is-paying-billions-to-treat-a-disease-it-could-have-prevented/",
        "date": "2026-03-26",
        "published_at": "2026-03-26T07:58:11Z",
        "sentiment": {
          "label": "negative",
          "score": -0.421,
          "confidence": 0.42
        }
      },
      {
        "source": "news",
        "source_name": "Biblegateway.com",
        "title": "Chronological Reading for Thursday March 26, 2026 (NIV)",
        "description": "",
        "url": "https://www.biblegateway.com/reading-plans/chronological/2026/03/26/",
        "date": "2026-03-26",
        "published_at": "2026-03-26T04:05:04Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Eclipsesource.com",
        "title": "The Eclipse Theia Community Release 2026-02",
        "description": "We are happy to announce the thirteenth Eclipse Theia community release, “2026-02,” incorporating the latest advances from Theia releases 1.67 and 1.68.\nNew to Eclipse Theia? It is the next-generation …The post The Eclipse Theia Community Release 2026-02\nappe…",
        "url": "https://eclipsesource.com/blogs/2026/03/26/the-eclipse-theia-community-release-2026-02/",
        "date": "2026-03-26",
        "published_at": "2026-03-26T00:00:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.572,
          "confidence": 0.57
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Show HN: Sift – local, de-noised GitHub notifications",
        "description": "Sift is an open source local GitHub inbox organizer.GitHub notifications are good at collecting activity and weak at prioritizing it. Sift pulls your inbox and adjacent repo activity into a local SQLite database, classifies it with explicit rules, and gives y…",
        "url": "https://github.com/vignesh07/sift",
        "date": "2026-03-25",
        "published_at": "2026-03-25T17:39:07Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD",
        "description": "DUBLIN, March 25, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today announced two peer-reviewed …",
        "url": "https://www.globenewswire.com/news-release/2026/03/25/3262385/0/en/GH-Research-Announces-Publication-of-Phase-2b-Results-for-Mebufotenin-GH001-in-JAMA-Psychiatry-and-Reports-New-Finding-of-Severity-Independent-Efficacy-in-TRD.html",
        "date": "2026-03-25",
        "published_at": "2026-03-25T15:10:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.178,
          "confidence": 0.18
        }
      },
      {
        "source": "news",
        "source_name": "Plos.org",
        "title": "Assessment of long COVID symptom burden in patients testing positive for SARS-CoV-2 at a nationwide retail pharmacy",
        "description": "Background Numerous grouping and scoring methodologies have been proposed to assess long COVID symptomatology. One approach is to use symptom count as a simple, quantifiable measure of long COVID symptom burden.   Methods This was a secondary analysis of a na…",
        "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345639",
        "date": "2026-03-25",
        "published_at": "2026-03-25T14:00:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.296,
          "confidence": 0.3
        }
      },
      {
        "source": "news",
        "source_name": "Plos.org",
        "title": "M5 positive allosteric modulation alleviates parkinsonian motor deficits",
        "description": "Parkinson’s disease is a neurodegenerative movement disorder which is characterized by cardinal motor symptoms of tremor at rest, rigidity, bradykineasia, and postural instability. Underlying these cardinal motor symptoms is thought to be death and dysfunctio…",
        "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345115",
        "date": "2026-03-25",
        "published_at": "2026-03-25T14:00:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.572,
          "confidence": 0.57
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "graniteclaw added to PyPI",
        "description": "Agent specification certification pipeline — from skill specs to governed, certified Mellea pipelines",
        "url": "https://pypi.org/project/graniteclaw/",
        "date": "2026-03-25",
        "published_at": "2026-03-25T12:43:20Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Show HN: Clinic – Connect your agent to Gmail, GitHub, Notion and 39 more (OSS)",
        "description": "Your AI agent can't access your Gmail, your GitHub, or your Notion. Most of these services already have CLIs built for programmatic access, but nobody's set them up, authenticated them, and told the agent they're there.Clinic does it in one command: clinic in…",
        "url": "https://github.com/jwvictor/clinic",
        "date": "2026-03-25",
        "published_at": "2026-03-25T12:42:39Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "OSP withdraws charges against two accused in NPA Trial",
        "description": "The Office of the Special Prosecutor (OSP) has withdrawn charges against two persons who were standing trial together with former Chief Executive of the National Petroleum Authority (NPA), Dr Mustapha Abdul-Hamid, and others in an alleged extortion case. The …",
        "url": "https://thechronicle.com.gh/osp-withdraws-charges-against-two-accused-in-npa-trial/",
        "date": "2026-03-25",
        "published_at": "2026-03-25T09:29:03Z",
        "sentiment": {
          "label": "negative",
          "score": -0.34,
          "confidence": 0.34
        }
      },
      {
        "source": "news",
        "source_name": "Yahoo Entertainment",
        "title": "What Does GH Research PLC (GHRS)’s Clinical Progress Updates Say?",
        "description": "",
        "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_4821a93d-833b-4229-a256-4e7bc617a16b",
        "date": "2026-03-25",
        "published_at": "2026-03-25T05:34:14Z",
        "sentiment": {
          "label": "positive",
          "score": 0.421,
          "confidence": 0.42
        }
      },
      {
        "source": "news",
        "source_name": "Hacker News",
        "title": "Show HN: GitHub Actions for Agents",
        "description": "Hi everyone,I really dislike the fix, commit, and wait loop that is involved with CI. I decided to fix that by shortening the loop. I did that by mocking the GH Actions control pane: the runner is the official GH runner, but the API is a mock.What you get is …",
        "url": "https://news.ycombinator.com/item?id=47513068",
        "date": "2026-03-25",
        "published_at": "2026-03-25T03:56:51Z",
        "sentiment": {
          "label": "negative",
          "score": -0.295,
          "confidence": 0.3
        }
      },
      {
        "source": "news",
        "source_name": "Frontendfoc.us",
        "title": "The Great CSS Expansion: Replacing JS with native features",
        "description": "<table>\n <tr><td>\n \n<table><tr><td></td></tr></table>\n\n<table><tr><td></td></tr></table>\n<table><tr><td>\n\n<table><tr><td>\n <table>\n <tr>\n <td>\n <table><tr><td> Frontend Focus</td></tr></table>\n\n #​734 — March 25, 2026 | Read on the web\r\n\n </td>\n </tr>\n </ta…",
        "url": "https://frontendfoc.us/issues/734",
        "date": "2026-03-25",
        "published_at": "2026-03-25T00:00:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.625,
          "confidence": 0.62
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "p6xer-mcp-server added to PyPI",
        "description": "MCP server for Primavera P6 XER schedule files — parse, analyze, and quality-check with AI",
        "url": "https://pypi.org/project/p6xer-mcp-server/",
        "date": "2026-03-24",
        "published_at": "2026-03-24T18:10:39Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "git-sift added to PyPI",
        "description": "Interactive wizard for reviewing AI-generated code changes by risk",
        "url": "https://pypi.org/project/git-sift/",
        "date": "2026-03-24",
        "published_at": "2026-03-24T16:14:52Z",
        "sentiment": {
          "label": "negative",
          "score": -0.273,
          "confidence": 0.27
        }
      },
      {
        "source": "news",
        "source_name": "Plos.org",
        "title": "Subject-specific modeling of response to physical stress via hypothalamic-pituitary-adrenal and sympathoadrenal axes",
        "description": "The two main pathways for hormonal stress response are the hypothalamic-pituitary- adrenal (HPA) axis and the sympathoadrenal (SA) axis. The HPA axis produces and secretes cortisol, while the SA axis produces and secretes the fast-acting catecholamines, epine…",
        "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0344981",
        "date": "2026-03-24",
        "published_at": "2026-03-24T14:00:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.681,
          "confidence": 0.68
        }
      },
      {
        "source": "news",
        "source_name": "Plos.org",
        "title": "Risk assessment for cardiovascular adverse drug events in the ICU: Case study on COVID-19 patients",
        "description": "The COVID-19 outbreak quickly became a pandemic. In Brazil, more than seven million cases were recorded in 2020. Most patients affected by the disease were admitted to intensive care units (ICU), requiring qualitative polypharmacy, increasing the risk of seri…",
        "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345280",
        "date": "2026-03-24",
        "published_at": "2026-03-24T14:00:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.455,
          "confidence": 0.45
        }
      },
      {
        "source": "news",
        "source_name": "Barbero.tech",
        "title": "Mikael Barbero: Stop trusting mutable references: how Eclipse Foundation projects should harden GitHub Actions after the Trivy compromise",
        "description": "On March 19, 2026, an attacker used compromised credentials to publish a malicious Trivy v0.69.4 release, force-push 76 of 77 version tags in aquasecurity/trivy-action, and replace all 7 tags in aquasecurity/setup-trivy with malicious commits. On March 22, Aq…",
        "url": "https://mikael.barbero.tech/blog/post/2026-03-24-stop-trusting-mutable-references/",
        "date": "2026-03-24",
        "published_at": "2026-03-24T08:30:00Z",
        "sentiment": {
          "label": "negative",
          "score": -0.477,
          "confidence": 0.48
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Show HN: ProofShot – Give AI coding agents eyes to verify the UI they build",
        "description": "Contribute to AmElmo/proofshot development by creating an account on GitHub.",
        "url": "https://github.com/AmElmo/proofshot",
        "date": "2026-03-24",
        "published_at": "2026-03-24T07:46:46Z",
        "sentiment": {
          "label": "positive",
          "score": 0.296,
          "confidence": 0.3
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Consolidated Bank Staff Steals GH¢1m And US$139k From Bank – Court Told",
        "description": "A 48-year-old Collateral Administrator at Consolidated Bank Ghana, Bonny Freddie Owusu Ansah, has been remanded into police custody by the Dansoman Circuit Court for allegedly stealing more than GH¢1 million and US$139,000 belonging to customers of the bank. …",
        "url": "https://thechronicle.com.gh/consolidated-bank-staff-steals-gh¢1m-and-us139k-from-bank-court-told/",
        "date": "2026-03-24",
        "published_at": "2026-03-24T07:28:10Z",
        "sentiment": {
          "label": "negative",
          "score": -0.791,
          "confidence": 0.79
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Dispatch Rider Pleads Guilty To Robbing  Namibian High Commissioner’s Secretary",
        "description": "The Circuit Court at Dansoman, presided over by Her Honour Nancy Teiko Searyoh, has fixed April 1, 2026, to sentence a 24-year-old dispatch rider who pleaded guilty to robbery and causing unlawful damage. The accused, Daniel Asiuebi, pleaded guilty simplicite…",
        "url": "https://thechronicle.com.gh/dispatch-rider-pleads-guilty-to-robbing-namibian-high-commissioners-secretary/",
        "date": "2026-03-24",
        "published_at": "2026-03-24T07:23:45Z",
        "sentiment": {
          "label": "negative",
          "score": -0.832,
          "confidence": 0.83
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Farmer services centre for Afram Plains",
        "description": "President John Dramani Mahama has announced plans for the construction of a long-awaited bridge over the Afram River, alongside major agricultural interventions, in what he describes as a decisive step toward transforming the Afram Plains. The announcement wa…",
        "url": "https://thechronicle.com.gh/farmer-services-centre-for-afram-plains/",
        "date": "2026-03-24",
        "published_at": "2026-03-24T07:20:34Z",
        "sentiment": {
          "label": "positive",
          "score": 0.226,
          "confidence": 0.23
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Know The Abolished Taxes in Ghana",
        "description": "Ghana’s Parliament has abolished several tax laws since 2024, a decision taken to enhance the tax system, lessen tax burdens on taxpayers, and promote economic growth. This move is part of the government’s RESET Agenda, aimed at reducing the tax burden on cit…",
        "url": "https://thechronicle.com.gh/know-the-abolished-taxes-in-ghana/",
        "date": "2026-03-24",
        "published_at": "2026-03-24T07:06:47Z",
        "sentiment": {
          "label": "negative",
          "score": -0.052,
          "confidence": 0.05
        }
      },
      {
        "source": "news",
        "source_name": "Thechronicle.com.gh",
        "title": "Editorial: Ghana’s Tomato Crisis Is A Policy Failure!",
        "description": "Over the weekend, Ghana’s media space was inundated with troubling developments from our northern neighbour, Burkina Faso. The country’s transitional military government, led by Ibrahim Traoré, has suspended the export of fresh tomatoes “until further notice”…",
        "url": "https://thechronicle.com.gh/editorial-ghanas-tomato-crisis-is-a-policy-failure/",
        "date": "2026-03-24",
        "published_at": "2026-03-24T07:03:26Z",
        "sentiment": {
          "label": "negative",
          "score": -0.918,
          "confidence": 0.92
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "ietf-notebook added to PyPI",
        "description": "Gather resources for an IETF Working Group for use in NotebookLM",
        "url": "https://pypi.org/project/ietf-notebook/",
        "date": "2026-03-24",
        "published_at": "2026-03-24T04:57:43Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "The Sun Chronicle",
        "title": "Attleboro's Capron Park Zoo sees a surge of visitors",
        "description": "ATTLEBORO — Capron Park Zoo saw a surge in visitors and membership sales this weekend — bringing in four times a typical March Saturday’s revenue — after Mayor Cathleen DeSimone announced plans to close the zoo as it currently operates.",
        "url": "https://www.thesunchronicle.com/newsletters/attleboros-capron-park-zoo-sees-a-surge-of-visitors/article_fa9f5e7d-7bf9-4b92-8dee-24a45f2d4ba1.html",
        "date": "2026-03-24",
        "published_at": "2026-03-24T04:30:00Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Show HN: QuarterMaster – Generate performance reviews from your GitHub activity",
        "description": "Every quarter I'd manually dig through merged PRs and feed them to an LLM to write my self-review. QuarterMaster automates this process.It fetches your PRs, code review activity, and commits, then generates a structured review.You can point it at a goals mark…",
        "url": "https://github.com/imponenm/QuarterMaster",
        "date": "2026-03-24",
        "published_at": "2026-03-24T03:18:54Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.026,
          "confidence": 0.03
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "ai-guardian added to PyPI",
        "description": "AI IDE security hook: blocks directories, scans secrets, and protects AI interactions",
        "url": "https://pypi.org/project/ai-guardian/",
        "date": "2026-03-24",
        "published_at": "2026-03-24T01:42:59Z",
        "sentiment": {
          "label": "positive",
          "score": 0.421,
          "confidence": 0.42
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Show HN: Upstack, Claude Code skills for red/green TDD",
        "description": "Inspired by Garry's gstack, upstack is a set of Claude Code skills designed for smaller-scale iterations to add finessed polish to our product that genuinely delights users. upstack's focus on red/green TDD and making screenshots and postman collections gives…",
        "url": "https://github.com/Upsolve-Labs/upstack",
        "date": "2026-03-23",
        "published_at": "2026-03-23T20:54:25Z",
        "sentiment": {
          "label": "positive",
          "score": 0.535,
          "confidence": 0.54
        }
      },
      {
        "source": "news",
        "source_name": "FDA.gov",
        "title": "FDA Drug Safety Communication: Safety review update of Recombinant Human Growth Hormone (somatropin) and possible increased risk of death",
        "description": "[8-4-2011] The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of recombinant human growth hormone (somatropin) and possible increased risk of death.",
        "url": "https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-safety-review-update-recombinant-human-growth-hormone-somatropin-and",
        "date": "2026-03-23",
        "published_at": "2026-03-23T16:52:43Z",
        "sentiment": {
          "label": "positive",
          "score": 0.586,
          "confidence": 0.59
        }
      },
      {
        "source": "news",
        "source_name": "Plos.org",
        "title": "Descriptions of the natural history of erythema nodosum leprosum to inform clinical classification – A semi-systematic review",
        "description": "Author summary Erythema nodosum leprosum (ENL) is a painful and often chronic immune-mediated complication of leprosy. It causes red nodules on the skin with fever and other organ inflammation. ENL may be severe and challenging to treat usually requiring immu…",
        "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014100",
        "date": "2026-03-23",
        "published_at": "2026-03-23T14:00:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.077,
          "confidence": 0.08
        }
      },
      {
        "source": "news",
        "source_name": "Github.com",
        "title": "Show HN: Oo – compress output for coding agents (cargo test → \"47 passed, 2.1s\")",
        "description": "I've been running coding agents heavily for the past year or so using frontier model APIs, open weight model APIs and, most recently, local models (Qwen family models on a Strix Halo).Starting to run local inference has highlighted something I've been aware f…",
        "url": "https://github.com/randomm/oo",
        "date": "2026-03-23",
        "published_at": "2026-03-23T12:41:07Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Kdnuggets.com",
        "title": "5 Tips to Turn OpenAI Codex Into a Powerful AI Coding Agent",
        "description": "Learn five practical ways to make OpenAI Codex more agentic, reliable, and useful for real software engineering workflows.",
        "url": "https://www.kdnuggets.com/5-tips-to-turn-openai-codex-into-a-powerful-ai-coding-agent",
        "date": "2026-03-23",
        "published_at": "2026-03-23T12:00:05Z",
        "sentiment": {
          "label": "positive",
          "score": 0.691,
          "confidence": 0.69
        }
      },
      {
        "source": "news",
        "source_name": "Ibtimes.com.au",
        "title": "Sony Xperia 2026 Smartphones: Xperia 1 VIII and Xperia 10 VIII Release Date Rumors and Specs Leaks",
        "description": "Sony Group Corp. is pushing forward with its Xperia smartphone lineup in 2026, with leaks and database filings confirming development of the flagship Xperia 1 VIII and mid-range Xperia 10 VIII. The Japanese tech giant reaffirmed its commitment to the mobile d…",
        "url": "https://www.ibtimes.com.au/sony-xperia-2026-smartphones-xperia-1-viii-xperia-10-viii-release-date-rumors-specs-leaks-1864132",
        "date": "2026-03-23",
        "published_at": "2026-03-23T09:58:04Z",
        "sentiment": {
          "label": "positive",
          "score": 0.459,
          "confidence": 0.46
        }
      },
      {
        "source": "news",
        "source_name": "Biblegateway.com",
        "title": "Old/New Testament Reading for Monday March 23, 2026 (NIV)",
        "description": "",
        "url": "https://www.biblegateway.com/reading-plans/old-new-testament/2026/03/23/",
        "date": "2026-03-23",
        "published_at": "2026-03-23T04:07:44Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "claude-ledger added to PyPI",
        "description": "Portfolio-level project tracking for Claude Code",
        "url": "https://pypi.org/project/claude-ledger/",
        "date": "2026-03-22",
        "published_at": "2026-03-22T23:27:39Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "gh-agent-sync 1.2.1",
        "description": "Link agents and skills from awesome-copilot or any common repos with agents/skills to your local repository.",
        "url": "https://pypi.org/project/gh-agent-sync/1.2.1/",
        "date": "2026-03-22",
        "published_at": "2026-03-22T17:47:16Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "gh-agent-sync added to PyPI",
        "description": "Link agents and skills from awesome-copilot to your local repository. Supports MCP-based git operations.",
        "url": "https://pypi.org/project/gh-agent-sync/",
        "date": "2026-03-22",
        "published_at": "2026-03-22T16:45:29Z",
        "sentiment": {
          "label": "positive",
          "score": 0.361,
          "confidence": 0.36
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "gh-agent-sync 0.1.0",
        "description": "Link agents and skills from awesome-copilot to your local repository. Supports MCP-based git operations.",
        "url": "https://pypi.org/project/gh-agent-sync/0.1.0/",
        "date": "2026-03-22",
        "published_at": "2026-03-22T16:45:29Z",
        "sentiment": {
          "label": "positive",
          "score": 0.361,
          "confidence": 0.36
        }
      },
      {
        "source": "news",
        "source_name": "Pypi.org",
        "title": "gh-cherry-pick added to PyPI",
        "description": "Cherry-pick commits across GitHub repositories using only the GitHub API - no local clone required",
        "url": "https://pypi.org/project/gh-cherry-pick/",
        "date": "2026-03-22",
        "published_at": "2026-03-22T10:20:13Z",
        "sentiment": {
          "label": "negative",
          "score": -0.273,
          "confidence": 0.27
        }
      },
      {
        "source": "pubmed",
        "pmid": "41917211",
        "title": "Phase 1 study of ceralasertib, an ATR kinase inhibitor, in combination with durvalumab in patients with recurrent or metastatic NSCLC or HNSCC.",
        "authors": "Lopez JS et al.",
        "journal": "British journal of cancer",
        "date": "2026 Mar 3",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41917211/",
        "sentiment": {
          "label": "negative",
          "score": -0.077,
          "confidence": 0.08
        }
      },
      {
        "source": "pubmed",
        "pmid": "41917040",
        "title": "Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER(+) HER2(-) locally-advanced or metastatic breast cancer.",
        "authors": "Liang J et al.",
        "journal": "Nature communications",
        "date": "2026 Apr 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41917040/",
        "sentiment": {
          "label": "negative",
          "score": -1.0,
          "confidence": 1.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41903996",
        "title": "Utility of Circulating Tumor DNA-Based Liquid Biopsies in Patients with Cancer Receiving Immunotherapy.",
        "authors": "Teixeira MF et al.",
        "journal": "Surgical oncology clinics of North America",
        "date": "2026-04-01",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41903996/",
        "sentiment": {
          "label": "negative",
          "score": -0.791,
          "confidence": 0.79
        }
      },
      {
        "source": "pubmed",
        "pmid": "41903301",
        "title": "Phase Ia/Ib trial of the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M).",
        "authors": "Kanemura H et al.",
        "journal": "European journal of cancer (Oxford, England : 1990)",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41903301/",
        "sentiment": {
          "label": "positive",
          "score": 0.527,
          "confidence": 0.53
        }
      },
      {
        "source": "pubmed",
        "pmid": "41899521",
        "title": "Association Between Patient-Reported Outcomes and Overall Survival in Patients with Advanced NSCLC Treated with First-Line Cemiplimab-Based Therapy.",
        "authors": "Gandara DR et al.",
        "journal": "Cancers",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41899521/",
        "sentiment": {
          "label": "positive",
          "score": 0.25,
          "confidence": 0.25
        }
      },
      {
        "source": "pubmed",
        "pmid": "41898529",
        "title": "Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer.",
        "authors": "Thu KL et al.",
        "journal": "International journal of molecular sciences",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41898529/",
        "sentiment": {
          "label": "negative",
          "score": -0.691,
          "confidence": 0.69
        }
      },
      {
        "source": "pubmed",
        "pmid": "41896648",
        "title": "Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.",
        "authors": "Cho BC et al.",
        "journal": "Nature medicine",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41896648/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41895789",
        "title": "Comparison of tissue acquisition techniques for Next-Generation Sequencing of non-small cell lung cancer (NSCLC).",
        "authors": "Bhamani A et al.",
        "journal": "BMJ open respiratory research",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41895789/",
        "sentiment": {
          "label": "negative",
          "score": -0.46,
          "confidence": 0.46
        }
      },
      {
        "source": "pubmed",
        "pmid": "41895314",
        "title": "Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration.",
        "authors": "Dingemans AC et al.",
        "journal": "The Lancet. Respiratory medicine",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41895314/",
        "sentiment": {
          "label": "negative",
          "score": -0.869,
          "confidence": 0.87
        }
      },
      {
        "source": "pubmed",
        "pmid": "41892875",
        "title": "Baseline tumor burden and outcomes in patients with rare cancers treated with immunotherapy (Southwest Oncology Group trial S1609).",
        "authors": "Swiecicki PL et al.",
        "journal": "Cancer",
        "date": "2026 Apr 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41892875/",
        "sentiment": {
          "label": "negative",
          "score": -0.67,
          "confidence": 0.67
        }
      },
      {
        "source": "pubmed",
        "pmid": "41883872",
        "title": "Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer.",
        "authors": "Qadri F et al.",
        "journal": "Therapeutic advances in medical oncology",
        "date": "2026-04-01",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41883872/",
        "sentiment": {
          "label": "negative",
          "score": -0.296,
          "confidence": 0.3
        }
      },
      {
        "source": "pubmed",
        "pmid": "41882405",
        "title": "Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.",
        "authors": "Park W et al.",
        "journal": "Nature medicine",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41882405/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41880871",
        "title": "Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST).",
        "authors": "Kito Y et al.",
        "journal": "European journal of cancer (Oxford, England : 1990)",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41880871/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41876649",
        "title": "AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.",
        "authors": "Woznitza N et al.",
        "journal": "Nature medicine",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41876649/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41874648",
        "title": "Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV).",
        "authors": "Mollica V et al.",
        "journal": "Cancer immunology, immunotherapy : CII",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41874648/",
        "sentiment": {
          "label": "positive",
          "score": 0.25,
          "confidence": 0.25
        }
      },
      {
        "source": "pubmed",
        "pmid": "41872602",
        "title": "Implementation of the NHS England Lung Cancer Screening Programme over 5 years.",
        "authors": "Lee RW et al.",
        "journal": "Nature medicine",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41872602/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41871874",
        "title": "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0.",
        "authors": "McKay RR et al.",
        "journal": "Journal for immunotherapy of cancer",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41871874/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41870735",
        "title": "Efficacy and safety of trastuzumab biosimilar CT-P6 plus SOX or CapeOX in HER2-positive advanced gastric cancer: a multicenter phase II KSCC-TROX study.",
        "authors": "Oki E et al.",
        "journal": "Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41870735/",
        "sentiment": {
          "label": "negative",
          "score": -0.153,
          "confidence": 0.15
        }
      },
      {
        "source": "pubmed",
        "pmid": "41866411",
        "title": "Efficacy and safety of peptide radionuclide therapy with (177)Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N).",
        "authors": "Okamoto K et al.",
        "journal": "Journal of gastroenterology",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41866411/",
        "sentiment": {
          "label": "positive",
          "score": 0.586,
          "confidence": 0.59
        }
      },
      {
        "source": "pubmed",
        "pmid": "41864749",
        "title": "Survival outcome of VATS compared with open lobectomy for lung cancer: an individual patient data meta-analysis of randomised trials.",
        "authors": "Harris RA et al.",
        "journal": "Lancet (London, England)",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41864749/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41861751",
        "title": "Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia.",
        "authors": "Rugo HS et al.",
        "journal": "ESMO open",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41861751/",
        "sentiment": {
          "label": "negative",
          "score": -0.382,
          "confidence": 0.38
        }
      },
      {
        "source": "pubmed",
        "pmid": "41861516",
        "title": "Multidisciplinary international expert consensus recommendations on tissue acquisition in non-small cell lung cancer.",
        "authors": "Lee P et al.",
        "journal": "EBioMedicine",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41861516/",
        "sentiment": {
          "label": "negative",
          "score": -0.46,
          "confidence": 0.46
        }
      },
      {
        "source": "pubmed",
        "pmid": "41858873",
        "title": "Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies.",
        "authors": "Sanchez-Cespedes M et al.",
        "journal": "JTO clinical and research reports",
        "date": "2026-04-01",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41858873/",
        "sentiment": {
          "label": "positive",
          "score": 0.296,
          "confidence": 0.3
        }
      },
      {
        "source": "pubmed",
        "pmid": "41851476",
        "title": "Real-world analysis of androgen receptor inhibitors in US patients with nonmetastatic castration-resistant prostate cancer: DEAR-EXT study.",
        "authors": "Shore ND et al.",
        "journal": "Prostate cancer and prostatic diseases",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41851476/",
        "sentiment": {
          "label": "negative",
          "score": -0.751,
          "confidence": 0.75
        }
      },
      {
        "source": "pubmed",
        "pmid": "41849281",
        "title": "Implementing a successful patient navigation program for follow-up colonoscopy: Lessons from the PRECISE study.",
        "authors": "Thompson JH et al.",
        "journal": "PloS one",
        "date": "2026-04-01",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41849281/",
        "sentiment": {
          "label": "positive",
          "score": 0.586,
          "confidence": 0.59
        }
      },
      {
        "source": "pubmed",
        "pmid": "41847154",
        "title": "Clinical Outcomes and Safety of Concurrent Chemoradiotherapy in EGFR-Mutant Unresectable Stage III NSCLC.",
        "authors": "Takamori S et al.",
        "journal": "JTO clinical and research reports",
        "date": "2026-04-01",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41847154/",
        "sentiment": {
          "label": "positive",
          "score": 0.421,
          "confidence": 0.42
        }
      },
      {
        "source": "pubmed",
        "pmid": "41843267",
        "title": "SEOM-TTCC clinical guidelines for the treatment of head and neck cancer (2025).",
        "authors": "Arrazubi V et al.",
        "journal": "Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41843267/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41840238",
        "title": "First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.",
        "authors": "Shitara K et al.",
        "journal": "Nature medicine",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41840238/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41832914",
        "title": "Impact of peritoneal metastasis on overall survival in patients with advanced endometrial cancer receiving lenvatinib plus pembrolizumab.",
        "authors": "Boku S et al.",
        "journal": "Discover oncology",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41832914/",
        "sentiment": {
          "label": "negative",
          "score": -0.527,
          "confidence": 0.53
        }
      },
      {
        "source": "pubmed",
        "pmid": "41830752",
        "title": "Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancer.",
        "authors": "Brufsky A et al.",
        "journal": "Breast (Edinburgh, Scotland)",
        "date": "2026-04-01",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41830752/",
        "sentiment": {
          "label": "negative",
          "score": -0.691,
          "confidence": 0.69
        }
      },
      {
        "source": "pubmed",
        "pmid": "41830429",
        "title": "Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity.",
        "authors": "Torrado C et al.",
        "journal": "The oncologist",
        "date": "2026 Mar 9",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41830429/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41825704",
        "title": "Coupled-enzyme assay for MTAP activity in biological samples.",
        "authors": "Gilaj N et al.",
        "journal": "Analytical biochemistry",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41825704/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41825178",
        "title": "Increased detection of NRG1 fusions in non-squamous non-small cell lung cancer using combined DNA and RNA sequencing in a real-world cohort.",
        "authors": "Araújo BJ et al.",
        "journal": "Lung cancer (Amsterdam, Netherlands)",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41825178/",
        "sentiment": {
          "label": "negative",
          "score": -0.511,
          "confidence": 0.51
        }
      },
      {
        "source": "pubmed",
        "pmid": "41819545",
        "title": "Evaluation of mixed response in tumor size and survival in patients with rare cancers treated with dual checkpoint inhibitor therapy (DART SWOG S1609).",
        "authors": "Chae YK et al.",
        "journal": "Journal for immunotherapy of cancer",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41819545/",
        "sentiment": {
          "label": "negative",
          "score": -0.44,
          "confidence": 0.44
        }
      },
      {
        "source": "pubmed",
        "pmid": "41819104",
        "title": "Cell-type-specific transposon demethylation and TAD remodeling in aging mouse brain.",
        "authors": "Zeng Q et al.",
        "journal": "Cell",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41819104/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41817930",
        "title": "ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.",
        "authors": "Kuemmel S et al.",
        "journal": "Annals of surgical oncology",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41817930/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41810446",
        "title": "Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics vs biosimilars.",
        "authors": "Moura CS et al.",
        "journal": "World journal of gastroenterology",
        "date": "2026 Mar 7",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41810446/",
        "sentiment": {
          "label": "positive",
          "score": 0.494,
          "confidence": 0.49
        }
      },
      {
        "source": "pubmed",
        "pmid": "41809424",
        "title": "Bridging paradigms and shaping the future of resectable gastric cancer: a narrative review of the post-MATTERHORN era.",
        "authors": "Okemoto D et al.",
        "journal": "Gastroenterology report",
        "date": "2026-04-01",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41809424/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41808570",
        "title": "Review of patient-reported outcomes in EMPOWER-Lung 1 in patients with advanced non-small cell lung cancer treated with cemiplimab versus chemotherapy.",
        "authors": "Gandara DR et al.",
        "journal": "Cancer",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41808570/",
        "sentiment": {
          "label": "negative",
          "score": -0.527,
          "confidence": 0.53
        }
      },
      {
        "source": "pubmed",
        "pmid": "41808091",
        "title": "Recovery from fulminant immune-related myocarditis induced by ipilimumab plus nivolumab in malignant pleural mesothelioma: a case report.",
        "authors": "Konya Y et al.",
        "journal": "BMC pulmonary medicine",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41808091/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41807638",
        "title": "Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics.",
        "authors": "Choo J et al.",
        "journal": "Nature reviews. Clinical oncology",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41807638/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41793510",
        "title": "A phase II study of atezolizumab in combination with stereotactic radiation for patients with triple-negative breast cancer and brain metastasis.",
        "authors": "Giordano A et al.",
        "journal": "Breast cancer research and treatment",
        "date": "2026 Mar 7",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41793510/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41792532",
        "title": "Ensuring High-Quality Rectal Cancer Surgery in an Era of Increasing Treatment Complexity.",
        "authors": "Brown KGM et al.",
        "journal": "Annals of surgical oncology",
        "date": "2026 Mar 6",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41792532/",
        "sentiment": {
          "label": "negative",
          "score": -0.511,
          "confidence": 0.51
        }
      },
      {
        "source": "pubmed",
        "pmid": "41790338",
        "title": "Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI).",
        "authors": "Shibuki T et al.",
        "journal": "International journal of clinical oncology",
        "date": "2026 Mar 6",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41790338/",
        "sentiment": {
          "label": "positive",
          "score": 0.477,
          "confidence": 0.48
        }
      },
      {
        "source": "pubmed",
        "pmid": "41781623",
        "title": "Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.",
        "authors": "Safonov A et al.",
        "journal": "Nature",
        "date": "2026 Mar 4",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41781623/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41780642",
        "title": "Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease.",
        "authors": "Curigliano G et al.",
        "journal": "Annals of oncology : official journal of the European Society for Medical Oncology",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41780642/",
        "sentiment": {
          "label": "negative",
          "score": -0.823,
          "confidence": 0.82
        }
      },
      {
        "source": "pubmed",
        "pmid": "41779341",
        "title": "Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.",
        "authors": "Kawagoe R et al.",
        "journal": "International journal of clinical oncology",
        "date": "2026 Mar 4",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41779341/",
        "sentiment": {
          "label": "negative",
          "score": -0.869,
          "confidence": 0.87
        }
      },
      {
        "source": "pubmed",
        "pmid": "41772242",
        "title": "ASO Visual Abstract: Incidence and Predictors of Neoplastic Diagnosis in Patients with a Clinically Abnormal Appendix.",
        "authors": "Gowda T et al.",
        "journal": "Annals of surgical oncology",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41772242/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41761577",
        "title": "Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: the BEETS (JACCRO CC‑18) study.",
        "authors": "Kotani D et al.",
        "journal": "The oncologist",
        "date": "2026 Mar 9",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41761577/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "pubmed",
        "pmid": "41616774",
        "title": "Emerging landscape of KRAS inhibitors in cancer treatment.",
        "authors": "Riedl JM et al.",
        "journal": "Cancer cell",
        "date": "2026 Mar 9",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41616774/",
        "sentiment": {
          "label": "negative",
          "score": -0.751,
          "confidence": 0.75
        }
      },
      {
        "source": "reddit",
        "subreddit": "getagraph",
        "title": "Buy Signal Guardant Health Inc - 3 Mar 2026 @ 15:35 -> USD93.91",
        "text": "Ticker: **GH**\n\nExchange: **NASDAQ**\n\nTime: **3 Mar 2026 @ 15:35**\n\nPrice: **USD93.91**\n\nLink: https://getagraph.com/NASDAQ/stock/live-signals/GH/ENG",
        "author": "jvc72",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-03",
        "url": "https://reddit.com/r/getagraph/comments/1rk0rxn/buy_signal_guardant_health_inc_3_mar_2026_1535/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "DeepFuckingValue",
        "title": "After-Hours Gainers and Losers for Today (March 24, 2026) 📈 📉",
        "text": "Here are today's top after-hours performers showing the biggest moves after regular trading hours.\n\n## 📈 After-Hours Gainers:\n\n| Symbol | Company | After-Hours | Regular Hours | Change | %Change |\n|:-------|:--------|:----------:|:-------------:|:------:|:-------:|\n| [ARM](https://marketrodeo.com/asset/ARM) | Arm Holdings plc American Depositary Shares | 144.76 | 134.96 | +9.80 | +7.26% |\n| [LTM](https://marketrodeo.com/asset/LTM) | LATAM Airlines Group S.A. | 51.50 | 49.03 | +2.47 | +5.04% |\n| ",
        "author": "MarketRodeo",
        "score": 3,
        "num_comments": 0,
        "date": "2026-03-24",
        "url": "https://reddit.com/r/DeepFuckingValue/comments/1s2qaha/afterhours_gainers_and_losers_for_today_march_24/",
        "sentiment": {
          "label": "negative",
          "score": -0.527,
          "confidence": 0.53
        }
      },
      {
        "source": "reddit",
        "subreddit": "DeepFuckingValue",
        "title": "After-Hours Gainers and Losers for Today (March 13, 2026) 📈 📉",
        "text": "Here are today's top after-hours performers showing the biggest moves after regular trading hours.\n\n## 📈 After-Hours Gainers:\n\n| Symbol | Company | After-Hours | Regular Hours | Change | %Change |\n|:-------|:--------|:----------:|:-------------:|:------:|:-------:|\n| [CHKP](https://marketrodeo.com/asset/CHKP) | Check Point Software Technologies Ltd. | 181.23 | 153.65 | +27.58 | +17.95% |\n| [STLD](https://marketrodeo.com/asset/STLD) | Steel Dynamics, Inc. | 199.24 | 170.60 | +28.64 | +16.79% |\n| ",
        "author": "MarketRodeo",
        "score": 3,
        "num_comments": 1,
        "date": "2026-03-13",
        "url": "https://reddit.com/r/DeepFuckingValue/comments/1rszlgw/afterhours_gainers_and_losers_for_today_march_13/",
        "sentiment": {
          "label": "negative",
          "score": -0.527,
          "confidence": 0.53
        }
      },
      {
        "source": "reddit",
        "subreddit": "Swing_Trader_Trading",
        "title": "Middle East war begins – stocks drop – Update 03/09/26",
        "text": "[Blog Post:](https://positiontrader.blog/2026/03/09/middle-east-war-begins-stocks-drop-update-03-09-26/)\n\nhttps://preview.redd.it/kf19dhculjng1.png?width=877&format=png&auto=webp&s=5f11966e2029af18cd9e91fec37a0655543a614d\n\n* [**Quant 30** ](https://positiontrader.blog/2026/03/09/middle-east-war-begins-stocks-drop-update-03-09-26/#portfolio)**– Up over 26% since June 2025**\n* **Quant Weekly – Up over 27% since June** **2025**\n* **Legacy – Up over 270% since April 2023**\n* [**Education** ](https:/",
        "author": "Swing_Trader_Trading",
        "score": 2,
        "num_comments": 1,
        "date": "2026-03-09",
        "url": "https://reddit.com/r/Swing_Trader_Trading/comments/1roycq7/middle_east_war_begins_stocks_drop_update_030926/",
        "sentiment": {
          "label": "negative",
          "score": -0.718,
          "confidence": 0.72
        }
      },
      {
        "source": "reddit",
        "subreddit": "Swing_Trader_Trading",
        "title": "Extreme fear grips the stock market – stock drop slows – Update 03/16/26",
        "text": "[Blog Post:](https://positiontrader.blog/2026/03/16/extreme-fear-grips-the-stock-market-stock-drop-slows-update-03-16-26/)\n\nhttps://preview.redd.it/ol6riok5g2pg1.png?width=1793&format=png&auto=webp&s=5d0155bc6fd0f1b0fafa9d68bccc95c29c00823d\n\n* [**Quant 30** ](https://positiontrader.blog/2026/03/16/extreme-fear-grips-the-stock-market-stock-drop-slows-update-03-16-26/#portfolio)**– Up over 24% since June 2025**\n* **Quant Weekly – Up over 26% since June** **2025**\n* **Legacy – Up over 270% since Ap",
        "author": "Swing_Trader_Trading",
        "score": 2,
        "num_comments": 0,
        "date": "2026-03-16",
        "url": "https://reddit.com/r/Swing_Trader_Trading/comments/1rv7j7d/extreme_fear_grips_the_stock_market_stock_drop/",
        "sentiment": {
          "label": "negative",
          "score": -0.68,
          "confidence": 0.68
        }
      },
      {
        "source": "reddit",
        "subreddit": "pancreaticcancer",
        "title": "Guardant liquid biopsy BRCA2",
        "text": "anyone have Guardant and have something as 0.3% and it be relevant on tissue. my husband has several markers but two of ones that popped up as low level BRCA2 Y3308 as 0.3% and wondering if it's just noise. waiting for tissue but just curious. He has some that are higher but I'm pretty sure they can't be targeted. Thanks in advance.",
        "author": "Any_Tumbleweed_7601",
        "score": 6,
        "num_comments": 5,
        "date": "2026-03-29",
        "url": "https://reddit.com/r/pancreaticcancer/comments/1s71r2e/guardant_liquid_biopsy_brca2/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "Quantisnow",
        "title": "Guardant Health's InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan",
        "text": "",
        "author": "Quantisnow",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-30",
        "url": "https://reddit.com/r/Quantisnow/comments/1s7opko/guardant_healths_infinityai_realworld_evidence/",
        "sentiment": {
          "label": "positive",
          "score": 0.735,
          "confidence": 0.74
        }
      },
      {
        "source": "reddit",
        "subreddit": "Quantisnow",
        "title": "Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data",
        "text": "",
        "author": "Quantisnow",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-24",
        "url": "https://reddit.com/r/Quantisnow/comments/1s2dj2p/verana_health_and_guardant_health_partner_to/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "RWATimes",
        "title": "Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection ...",
        "text": "![](https://mms.businesswire.com/media/20260318529389/en/1330243/22/GuardantHealthLogo_TM_RGB-2C.jpg)\n\n-Guardant Reveal demonstrates expanded utility in identifying new, primary cancers during minimal residual disease (MRD) monitoringStudies show strong performance of Guardant360 Tissue in determining  ...\n\n **Details:**\n- **Published:** 18/03/2026 12:05 (UTC)\n- **📊 Characteristics Score:**\n  > **Asset Type:** *others*\n  > **Sentiment:** `0.3`\n  > **Entropy:** `0.75`\n  > **Relevance:** `0.9`\n  >",
        "author": "rwatimes",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-22",
        "url": "https://reddit.com/r/RWATimes/comments/1s0dfot/guardant_health_to_present_28_abstracts/",
        "sentiment": {
          "label": "negative",
          "score": -0.382,
          "confidence": 0.38
        }
      },
      {
        "source": "reddit",
        "subreddit": "Quantisnow",
        "title": "Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026",
        "text": "",
        "author": "Quantisnow",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-18",
        "url": "https://reddit.com/r/Quantisnow/comments/1rx23dm/guardant_health_to_present_28_abstracts/",
        "sentiment": {
          "label": "negative",
          "score": -0.382,
          "confidence": 0.38
        }
      },
      {
        "source": "reddit",
        "subreddit": "Quantisnow",
        "title": "Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership",
        "text": "",
        "author": "Quantisnow",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-16",
        "url": "https://reddit.com/r/Quantisnow/comments/1rv7mrt/guardant_health_launches_shield_multicancer/",
        "sentiment": {
          "label": "positive",
          "score": 0.2,
          "confidence": 0.2
        }
      },
      {
        "source": "reddit",
        "subreddit": "Quantisnow",
        "title": "New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare",
        "text": "",
        "author": "Quantisnow",
        "score": 2,
        "num_comments": 0,
        "date": "2026-03-13",
        "url": "https://reddit.com/r/Quantisnow/comments/1rsljb0/new_guardant_healthharris_poll_survey_shows_92_of/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "reddit",
        "subreddit": "Quantisnow",
        "title": "Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics",
        "text": "",
        "author": "Quantisnow",
        "score": 2,
        "num_comments": 0,
        "date": "2026-03-10",
        "url": "https://reddit.com/r/Quantisnow/comments/1rpv5qg/guardant_healths_shield_bloodbased_screening_test/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "reddit",
        "subreddit": "Penny_Stock_USA",
        "title": "Guardant’s new Shield screening tour shows blood-based testing is moving into real-world rollout",
        "text": "https://preview.redd.it/c09uxs4b52ng1.png?width=315&format=png&auto=webp&s=265801915d05560931fe4bd597ec820cbe50a057\n\nToday Guardant Health launched \"Shield Across America\", a coast-to-coast mobile screening tour that will bring its Shield colorectal cancer blood test to over 100 U.S. communities, with a stated focus on rural areas that have low screening rates and higher CRC incidence and mortality.\n\nGuardant is tying the rollout to real-world completion behavior, citing 93% patient adherence in",
        "author": "UnlicensedWizard78",
        "score": 2,
        "num_comments": 0,
        "date": "2026-03-04",
        "url": "https://reddit.com/r/Penny_Stock_USA/comments/1rkqiwn/guardants_new_shield_screening_tour_shows/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "Quantisnow",
        "title": "Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America",
        "text": "",
        "author": "Quantisnow",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-04",
        "url": "https://reddit.com/r/Quantisnow/comments/1rkjntr/guardant_health_launches_coasttocoast_screening/",
        "sentiment": {
          "label": "negative",
          "score": -0.66,
          "confidence": 0.66
        }
      },
      {
        "source": "reddit",
        "subreddit": "Quantisnow",
        "title": "Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened",
        "text": "",
        "author": "Quantisnow",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-03",
        "url": "https://reddit.com/r/Quantisnow/comments/1rjnjjd/actor_and_cancer_advocate_patrick_dempsey/",
        "sentiment": {
          "label": "negative",
          "score": -0.791,
          "confidence": 0.79
        }
      },
      {
        "source": "reddit",
        "subreddit": "exactsciences",
        "title": "Exact Sciences Is Now Abbott!",
        "text": "As result of the Merger, on March 23, 2026, a change in control of Exact occurred, and Exact is now a direct, wholly owned subsidiary of Abbott Laboratories \n\nIt has been one heckuva run for long-time Exact Sciences shareholders! \n\nA roller coaster ride for sure at times. But always, for me at least, more than just an investment, but about being a part of the Company's mission to eradicate cancer and alleviate human suffering.\n\nAnd so many memories! \n\nWho can forget the fiasco in 2015, when Colo",
        "author": "Superchief440",
        "score": 17,
        "num_comments": 15,
        "date": "2026-03-23",
        "url": "https://reddit.com/r/exactsciences/comments/1s1mbwy/exact_sciences_is_now_abbott/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "heraldry",
        "title": "After a year, I'm ready for critiques!",
        "text": "Hello all!      I started work on my assumed coat of arms this time last year, as trying to find if my Scottish ancestors possessed a COA was futile.\n\nAfter much research, deep contemplation, and countless edits, I think I finally have it right, and wishing for public opinion. I am open for your critiques! Before applying to and paying the $395 fee to the American College of Heraldry, as well as registering with the New England Committee on Heraldry, may I have your professional opinion and revi",
        "author": "EccentricArchivist",
        "score": 0,
        "num_comments": 17,
        "date": "2026-03-15",
        "url": "https://reddit.com/r/heraldry/comments/1ru63q2/after_a_year_im_ready_for_critiques/",
        "sentiment": {
          "label": "positive",
          "score": 0.42,
          "confidence": 0.42
        }
      },
      {
        "source": "reddit",
        "subreddit": "heraldry",
        "title": "Remade personal arms after last post",
        "text": "I wanted to make a coat of arms for my house, where I have rescued a lot of cats and dogs, which led to my online handle ''The Cat Fortress'' \n\nI wanted to incorporate green as it is my favorite color and the overall color palette accidentally (but fortuitously) reflects the colors of my country, Brazil\n\nFor the crest I went with a white cat with blue eyes to represent one of the nicest, best cats I've rescued, A white flamepoint named Brie which is an elderly cat\n\nwould you help me blazon this ",
        "author": "thecatfortress",
        "score": 52,
        "num_comments": 8,
        "date": "2026-03-24",
        "url": "https://reddit.com/r/heraldry/comments/1s2g5oz/remade_personal_arms_after_last_post/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "heraldry",
        "title": "Help blazoning mirrored sets of daggers in saltire",
        "text": "please forgive the quick sketch, i put it together just as an example... i have been wondering how to blazon two sets of daggers in saltire, one set being inverted, without being repetitive. \n\nthe rough draft i had come up with for this example is “**Argent a pale Sable, charged with a lion’s head erased guardant proper, between in chief two daggers in saltire inverted Argent and in base two daggers in saltire Argent**”. i am now trying to properly condense it.\n\nmy primary question: **is there a",
        "author": "cailleachsith",
        "score": 26,
        "num_comments": 8,
        "date": "2026-03-30",
        "url": "https://reddit.com/r/heraldry/comments/1s7riey/help_blazoning_mirrored_sets_of_daggers_in_saltire/",
        "sentiment": {
          "label": "positive",
          "score": 0.402,
          "confidence": 0.4
        }
      },
      {
        "source": "reddit",
        "subreddit": "heraldry",
        "title": "How to blazon properly/order of words",
        "text": "This is a prototype of my arms, I have some tweaks to make of shades of colors, but they'll stay the same. \n\n  \nI understand the components of it, but am confused on the order. I know its a field of argent, a beaver rampant proper, (how do you say holding) a key or, and then idk how to say on a azure Chevron, with a crest of a cat sejant argent)",
        "author": "Cadet-Cryyx",
        "score": 9,
        "num_comments": 7,
        "date": "2026-03-25",
        "url": "https://reddit.com/r/heraldry/comments/1s3cig9/how_to_blazon_properlyorder_of_words/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "heraldry",
        "title": "Book Suggestions on Heraldry..",
        "text": "Hi everybody, im collecting books on heraldry as much as find anywhere but most of them old editions with b&w editions which doesnt bring any good to comprehend the essence at all.\n\nRecently came across with [this one](https://www.amazon.com/Illustrated-Book-Heraldry-International-Contemporary/dp/0754834603/) (see the second pic and continuous ones) *Lorenz Books Publishing by Stephen Slater*. And seems pretty comprehensive. What do you think about it? Do you have any other suggestions?\n\nThank y",
        "author": "lastmonday07",
        "score": 33,
        "num_comments": 5,
        "date": "2026-03-18",
        "url": "https://reddit.com/r/heraldry/comments/1rxe188/book_suggestions_on_heraldry/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "heraldry",
        "title": "Coat of arms of a fictitious country, created in the style of Vexald [blazon, feedback]",
        "text": "Coat of arms of a fictitious country, created in the style of Vexald. \n\nDoes anyone have any feedback on or issues with its heraldic form (\"correctness\")? \n\nWould also be grateful if someone more knowledgeable than I am in this field would be so kind as to generate a blazon for the full achievement. The blade being held by the lion passant guardant in the crest and escutcheon is known as a keris, which is also present in the chief.",
        "author": "lanara-royal",
        "score": 30,
        "num_comments": 3,
        "date": "2026-03-28",
        "url": "https://reddit.com/r/heraldry/comments/1s5ussb/coat_of_arms_of_a_fictitious_country_created_in/",
        "sentiment": {
          "label": "positive",
          "score": 0.25,
          "confidence": 0.25
        }
      },
      {
        "source": "reddit",
        "subreddit": "lungcancer",
        "title": "Bio marker testing",
        "text": "Hi \n\nMy mom 56F Asian with multiple pulmonary nodules was diagnosed with non small cell lung cancer. She is a non smoker.  There is a high chance this is due to a mutation as per the pulmonologist. The oncologist that we are about to meet has sent the tissue and liquid biopsy to Caris. I have only heard of foundation one and guardant for lung cancer. Is Caris a good place to get biomarker testing done for lung cancer? Any insights or experiences with this company? ",
        "author": "Kind-Shake-953",
        "score": 9,
        "num_comments": 7,
        "date": "2026-03-14",
        "url": "https://reddit.com/r/lungcancer/comments/1rty5xk/bio_marker_testing/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "breastcancer",
        "title": "Reoccurrence?",
        "text": "Hi there awesome community!\n\nI’m 40 now with TCHP chemo, DMX, radiation and the exchange surgery completed in 2024. My doc has been doing regular Guardant tests and in August was the last negative result. The December one showed ctDNA at under 0.05% and bloodwork now shows my CA27.29 marker at 20 vs 10 in december (still in the green and only over 38 is it considered reason for stress).\n\nMy oncologist said they won’t take any action such as tests until the cancer marker is higher in bloodowrk or",
        "author": "AnnaMariaaaaaaa",
        "score": 4,
        "num_comments": 4,
        "date": "2026-03-12",
        "url": "https://reddit.com/r/breastcancer/comments/1rs6bfd/reoccurrence/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      }
    ]
  }
}